0001140361-23-034303.txt : 20230712
0001140361-23-034303.hdr.sgml : 20230712
20230712204530
ACCESSION NUMBER: 0001140361-23-034303
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230712
FILED AS OF DATE: 20230712
DATE AS OF CHANGE: 20230712
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smith Brandon S.
CENTRAL INDEX KEY: 0001805226
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35676
FILM NUMBER: 231085595
MAIL ADDRESS:
STREET 1: C/O PROTHENA BIOSCIENCES INC.
STREET 2: 331 OYSTER POINT BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PROTHENA CORP PUBLIC LTD CO
CENTRAL INDEX KEY: 0001559053
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 77 SIR JOHN ROGERSON'S QUAY, BLOCK C
STREET 2: GRAND CANAL DOCKLANDS
CITY: DUBLIN 2
STATE: L2
ZIP: D02 VK60
BUSINESS PHONE: 011-353-1-236-2500
MAIL ADDRESS:
STREET 1: 77 SIR JOHN ROGERSON'S QUAY, BLOCK C
STREET 2: GRAND CANAL DOCKLANDS
CITY: DUBLIN 2
STATE: L2
ZIP: D02 VK60
FORMER COMPANY:
FORMER CONFORMED NAME: Prothena Corp plc
DATE OF NAME CHANGE: 20121102
FORMER COMPANY:
FORMER CONFORMED NAME: Neotope Corp Ltd
DATE OF NAME CHANGE: 20120926
4
1
form4.xml
X0407
4
2023-07-12
0001559053
PROTHENA CORP PUBLIC LTD CO
PRTA
0001805226
Smith Brandon S.
C/O PROTHENA BIOSCIENCES INC
331 OYSTER POINT BOULEVARD
SOUTH SAN FRANCISCO
CA
94080
true
Chief Operating Officer
true
Ordinary Shares, par value $0.01 per share
2023-07-12
4
M
0
4000
11.12
A
4000
D
Ordinary Shares, par value $0.01 per share
2023-07-12
4
S
0
3200
67.396
D
800
D
Ordinary Shares, par value $0.01 per share
2023-07-12
4
S
0
800
67.948
D
0
D
Stock Option (Right to Buy)
11.12
2023-07-12
4
M
0
4000
0
D
2030-03-02
Ordinary Shares
4000
230667
D
The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2023.
The transaction was executed in multiple trades in prices ranging from $66.815 to $67.76, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the ranges set forth in footnotes 2 through 3 of this Form 4.
The transaction was executed in multiple trades in prices ranging from $67.855 to $68.295, inclusive.
The shares subject to the option vested and became exercisable as to 25% of the total number of shares subject to the option on March 2, 2021, and will vest with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.
/s/ Michael J. Malecek as Attorney in Fact for Brandon S. Smith
2023-07-12